IP Library Granted Patent US 8,895,307
Granted Patent B2
US 8,895,307 · App. 13/550,565 · Granted Nov 25, 2014

Ketol-acid reductoisomerase using NADH

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,895,307
App. No.
13/550,565
Granted
Nov 25, 2014
Kind
B2
Abstract

Methods for the evolution of NADPH binding ketol-acid reductoisomerase enzymes to acquire NADH binding functionality are provided. Specific mutant ketol-acid reductoisomerase enzymes isolated from Pseudomonas that have undergone co-factor switching to bind NADH are described.

Claims (18)

1. A method for the evolution of a NADPH using ketol-acid reductoisomerase enzyme to an NADH using form comprising:

(a) providing a ketol-acid reductoisomerase enzyme wherein said ketol-acid reductoisomerase enzyme has an amino acid sequence that matches the Profile Hidden Markov Model for KARIs in Table 9 with an E value of <10 −3 using the HMMER 2.2 g hmmsearch program in the HMMER 2.2 g package with the Z parameter set to 1 billion and uses NADPH as a cofactor;

(b) identifying the cofactor switching residues in the enzyme of a) corresponding to the amino acids at positions 24, 33, 47, 50, 52, 53, 61, 80, 115, 156, 165, and 170 of SEQ ID NO: 17;

(c) creating mutations in at least two of the cofactor switching residues of b) to create a mutant enzyme, wherein one of the at least two mutations is a substitution of the cofactor switching residue corresponding to position 52 of SEQ ID NO: 17.

2. The method of claim 1 wherein the residue corresponding to position 52 of SEQ ID NO: 17 has an amino acid substitution selected from the group consisting of A, C, D, G, H, N, S, and wherein the at least one other mutation is selected from the group consisting of:

(a) the residue corresponding to position 47 of SEQ ID NO; 17 has an amino acid substitution selected from the group consisting of A, C, D, F, G, 1, L, N, P, and Y;

(b) the residue corresponding to position 50 of SEQ ID NO: 17 has an amino acid substitution selected from the group consisting of A, C, D, E, F, G, M, N, V, W;

(c) the residue corresponding to position 53 of SEQ ID NO: 17 has an amino acid substitution selected from the group consisting of A, H, I, W;

(d) the residue corresponding to position 156 of SEQ ID NO: 17 has an amino acid substitution of V;

(e) the residue corresponding to position 165 of SEQ ID NO: 17 has an amino acid substitution of M;

(f) the residue corresponding to position 61 of SEQ ID NO: 17 has an amino acid substitution of F;

(g) the residue corresponding to position 170 of SEQ ID NO: 17 has an amino acid substitution of A;

(h) the residue corresponding to position 24 of SEQ ID NO: 17 has an amino acid substitution of F;

(i) the residue corresponding to position 33 of SEQ ID NO: 17 has an amino acid substitution of L;

(j) the residue corresponding to position 80 of SEQ ID NO: 17 has an amino acid substitution of I;

(k) the residue corresponding to position 115 of SEQ ID NO: 17 has an amino acid substitution of L; and

(l) combinations thereof.

3. The method of claim 1 wherein the mutant ketol-acid reductoisomerase enzyme has the amino acid sequence of SEQ ID NO: 29.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2023
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: BUTAMAX ADVANCED BIOFUELS LLC
Reel/Frame 062538/0103 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2023
From: LI, YOUGEN; LIAO, DER-ING; NELSON, MARK J.; OKEEFE, DANIEL P.
To: E. I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 062400/0751 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2021
From: BUTAMAX ADVANCED BIOFUELS LLC
To: GEVO, INC.
Reel/Frame 057677/0477 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2021
From: TOMB, JEAN-FRANCOIS
To: BUTAMAX(TM) ADVANCED BIOFUELS LLC
Reel/Frame 057305/0763 →